Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

How hot can mitochondria be? Incubation at temperatures above 43 °C induces the degradation of respiratory complexes and supercomplexes in intact cells and isolated mitochondria

  • Moreno-Loshuertos, Raquel
  • Marco-Brualla, Joaquín
  • Meade, Patricia
  • Soler-Agesta, Ruth
  • Enriquez, José A.
  • Fernández-Silva, Patricio
Mitochondrial function generates an important fraction of the heat that contributes to cellular and organismal temperature maintenance, but the actual values of this parameter reached in the organelles is a matter of debate. The studies addressing this issue have reported divergent results: from detecting in the organelles the same temperature as the cell average or the incubation temperature, to increasing differences of up to 10 degrees above the incubation value. Theoretical calculations based on physical laws exclude the possibility of relevant temperature gradients between mitochondria and their surroundings. These facts have given rise to a conundrum or paradox about hot mitochondria. We have examined by Blue-Native electrophoresis, both in intact cells and in isolated organelles, the stability of respiratory complexes and supercomplexes at different temperatures to obtain information about their tolerance to heat stress. We observe that, upon incubation at values above 43 °C and after relatively short periods, respiratory complexes, and especially complex I and its supercomplexes, are unstable even when the respiratory activity is inhibited. These results support the conclusion that high temperatures (>43 °C) cause damage to mitochondrial structure and function and question the proposal that these organelles can physiologically work at close to 50 °C.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Local temperature increments and induced cell death in intracellular magnetic hyperthermia

  • Gu, Y.
  • Piñol, R.
  • Moreno-Loshuertos, R.
  • Brites, C. D. S.
  • Zeler, J.
  • Martínez, A.
  • Maurin-Pasturel, G.
  • Fernández-Silva, P.
  • Marco-Brualla, J.
  • Téllez, P.
  • Cases, R.
  • Navarro Belsué, R.
  • Bonvin, D.
  • Carlos, L. D.
  • Millán, Á.
The generation of temperature gradients on nanoparticles heated externally by a magnetic field is crucially important in magnetic hyperthermia therapy. But the intrinsic low heating power of magnetic nanoparticles, at the conditions allowed for human use, is a limitation that restricts the general implementation of the technique. A promising alternative is local intracellular hyperthermia, whereby cell death (by apoptosis, necroptosis, or other mechanisms) is attained by small amounts of heat generated at thermosensitive intracellular sites. However, the few experiments conducted on the temperature determination of magnetic nanoparticles have found temperature increments that are much higher than the theoretical predictions, thus supporting the local hyperthermia hypothesis. Reliable intracellular temperature measurements are needed to get an accurate picture and resolve the discrepancy. In this paper, we report the real-time variation of the local temperature on γ-Fe2O3 magnetic nanoheaters using a Sm3+/Eu3+ ratiometric luminescent thermometer located on its surface during exposure to an external alternating magnetic field. We measure maximum temperature increments of 8 °C on the surface of the nanoheaters without any appreciable temperature increase on the cell membrane. Even with magnetic fields whose frequency and intensity are still well within health safety limits, these local temperature increments are sufficient to produce a small but noticeable cell death, which is enhanced considerably as the magnetic field intensity is increased to the maximum level tolerated for human use, consequently demonstrating the feasibility of local hyperthermia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Enhancement of tumor cell immunogenicity and antitumor properties derived from platinum-conjugated iron nanoparticles

  • Hernández, Ángela-Patricia
  • Iglesias-Anciones, Laura
  • Vaquero-González, José Javier
  • Piñol, Rafael
  • Criado, Julio J.
  • Rodriguez, Emilio
  • Juanes-Velasco, Pablo
  • García-Vaquero, Marina L.
  • Arias-Hidalgo, Carlota
  • Orfao, Alberto
  • Millán, Ángel
  • Fuentes, Manuel
From chemistry design to clinical application, several approaches have been developed to overcome platinum drawbacks in antitumoral therapies. An in-depth understanding of intracellular signaling may hold the key to the relationship of both conventional drugs and nanoparticles. Within these strategies, first, nanotechnology has become an essential tool in oncotherapy, improving biopharmaceutical properties and providing new immunomodulatory profiles to conventional drugs mediated by activation of endoplasmic reticulum (ER) stress. Secondly, functional proteomics techniques based on microarrays have proven to be a successful method for high throughput screening of proteins and profiling of biomolecule mechanisms of action. Here, we conducted a systematic characterization of the antitumor profile of a platinum compound conjugated with iron oxide nanoparticles (IONPs). As a result of the nano-conjugation, cytotoxic and proteomics profiles revealed a significant improvement in the antitumor properties of the starting material, providing selectivity in certain tumor cell lines tested. Moreover, cell death patterns associated with immunogenic cell death (ICD) response have also been identified when ER signaling pathways have been triggered. The evaluation in several tumor cell lines and the analysis by functional proteomics techniques have shown novel perspectives on the design of new cisplatin-derived conjugates, the high value of IONPs as drug delivery systems and ICD as a rewarding approach for targeted oncotherapy and onco-immunotherapies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Isolation of Mitochondria for Mitochondrial Supercomplex Analysis from Small Tissue and Cell Culture Samples

  • Moreno-Loshuertos, Raquel
  • Fernández-Silva, Patricio
Over the last decades, the evidence accumulated about the existence of respiratory supercomplexes (SCs) has changed our understanding of the mitochondrial electron transport chain organization, giving rise to the proposal of the "plasticity model." This model postulates the coexistence of different proportions of SCs and complexes depending on the tissue or the cellular metabolic status. The dynamic nature of the assembly in SCs would allow cells to optimize the use of available fuels and the efficiency of electron transfer, minimizing reactive oxygen species generation and favoring the ability of cells to adapt to environmental changes. More recently, abnormalities in SC assembly have been reported in different diseases such as neurodegenerative disorders (Alzheimer's and Parkinson's disease), Barth Syndrome, Leigh syndrome, or cancer. The role of SC assembly alterations in disease progression still needs to be confirmed. Nevertheless, the availability of enough amounts of samples to determine the SC assembly status is often a challenge. This happens with biopsy or tissue samples that are small or have to be divided for multiple analyses, with cell cultures that have slow growth or come from microfluidic devices, with some primary cultures or rare cells, or when the effect of particular costly treatments has to be analyzed (with nanoparticles, very expensive compounds, etc.). In these cases, an efficient and easy-to-apply method is required. This paper presents a method adapted to obtain enriched mitochondrial fractions from small amounts of cells or tissues to analyze the structure and function of mitochondrial SCs by native electrophoresis followed by in-gel activity assays or western blot.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Enhanced luminescence of (Eu3+/Sm3+)(diketone)3(N-Base) complexes enabled by ancillary ligands

  • Maurin-Pasturel, Guillaume
  • Piñol, Rafael
  • Cases, Rafael
  • Brites, Carlos D.S.
  • Saraiva, Leonardo F.
  • Carneiro Neto, Albano N.
  • Ara, Irene
  • Falvello, Larry
  • Sanjuán, Marisa
  • Carlos, Luís D.
  • Millán, Angel
Lanthanide β-diketonate complexes are prominent luminescent materials due to their intense, spectrally pure emissions and their broad utility in sensing, display technologies, and photonics. Their efficiency, however, depends critically on the effectiveness of ligand-to-metal energy transfer and the suppression of non-radiative deactivation. Introducing ancillary N-donor ligands enhances these processes by improving energy-transfer efficiency and reducing vibrational quenching. We report a family of Eu3+ and Sm3+ complexes of general formula LnL3L*, where L is a β-diketonate (4,4,4- trifluoro-1-phenyl-1,3-butanedionate, btfa− , or 2-thenoyltrifluoroacetate, tta− ) and L* a bidentate (1,10-phenanthroline) or tridentate (terpyridine derivatives) N-donor ligand. The complexes were synthesized and characterized by single-crystal and powder X-ray diffraction, Raman, and IR spectroscopies. Photophysical measurements, supported by computational analysis, reveal clear structure–property correlations. All complexes exhibit markedly enhanced emission relative to the parent LnL3⋅2H2O species (Ln = Eu and Sm). The highest luminescence intensities were obtained with 4′(4-methyl)-2,2′:6′,2″-terpyridine, followed by 1,10-phenanthroline, 2,2′:6′,2″-terpyridine, and 2,6-bis(5-(p-methoxyphenyl)-1H-pyrazol-3-yl)pyridine. Overall, these results highlight the critical role of ancillary N-donor ligands in tuning lanthanide photophysics, thereby enabling enhanced emission efficiency and tailored optical properties for advanced luminescent technologies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Clinical and molecular characterization of a novel pathogenic AIFM1 E336K mutation connecting mitochondrial dysfunction and neurodegeneration

  • Ferrer, Miguel
  • Pedrón, María
  • Soriano, Olga
  • Martínez-Julvez, Marta
  • Marín-Baquero, Mikel
  • García-Villanueva, Rut
  • Velázquez-Campoy, Adrián
  • Marco-Brualla, Joaquín
  • Ripollés-Yuba, Cristina
  • Fernández-Silva, Patricio
  • Medina, Milagros
  • Miramar, María Dolores
  • Bestué, María
  • Moreno-Loshuertos, Raquel
  • Ferreira, Patricia
Mutations in the AIFM1 gene, encoding the apoptosis-inducing factor (AIF), have been associated with a spectrum of neurometabolic disorders. However, the mechanistic basis underlying their pathogenicity remains poorly understood. In this work, we identified and comprehensively characterized a novel hemizygous AIFM1 mutation c.1006G > A (E336K) in a male patient presenting with a progressive hereditary axonal sensorimotor polyneuropathy with childhood onset, inherited in an X-linked recessive pattern, associated with sensorineural hearing loss and without cognitive impairment. The clinical phenotype was consistent with Charcot-Marie-Tooth disease type 4 (CMTX4). Patient-derived fibroblasts exhibited reduced AIF protein stability despite preserved mRNA expression, impaired growth in OXPHOS-dependent conditions, decreased basal respiration, and altered assembly of mitochondrial respiratory supercomplexes. These defects were accompanied by reduced CHCHD4 protein levels and mitochondrial content. The purified E336K protein exhibited compromised FAD retention, decreased thermal stability, impaired NADH affinity, destabilization of the charge-transfer complex crucial for sustaining the AIF: CHCHD4 interaction, and a shift in coenzyme preference toward NADPH. Structurally, the substitution of Glu336 with Lys remodels the electrostatic environment of the NADH-binding cleft, thereby compromising redox function and weakening CHCHD4 binding. Despite these defects, the protein with the E336K mutation retained DNA binding, nuclease activity, and binding to nuclear partners, although parthanatos induction was attenuated in patient fibroblasts. Collectively, these molecular alterations converge on defective mitochondrial bioenergetics and dynamics, providing a direct mechanistic link to the patient’s clinical evolution. These findings provide a framework for understanding AIFM1-related disorders and pave the way for the development of future personalized molecular therapies.